Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. The... Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service and accessories stream. The company generates the majority of revenue from the United States. Show more
ST. LOUIS and SHANGHAI, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) and Shanghai MicroPort EP Medtech Co., Ltd. (688351.SH, “MicroPort EP”), today announced that the Magbot™...
ST. LOUIS and SHENYANG, China, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) and Neusoft Medical Systems Co., Ltd (“Neusoft Medical Systems”) today announced that Stereotaxis’...
ST. LOUIS, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that...
ST. LOUIS and SHANGHAI, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) and Shanghai MicroPort EP Medtech Co., Ltd. (688351.SH, “MicroPort EP”), today announced regulatory approval of...
ST. LOUIS, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that...
ST. LOUIS, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial...
ST. LOUIS, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that...
ST. LOUIS, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it...
ST. LOUIS, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.1414 | 6.39819004525 | 2.21 | 2.505 | 2.1801 | 416959 | 2.33611443 | CS |
4 | 0.3014 | 14.7024390244 | 2.05 | 2.595 | 2.025 | 417159 | 2.27228839 | CS |
12 | 0.3314 | 16.4059405941 | 2.02 | 2.595 | 1.82 | 299744 | 2.12373647 | CS |
26 | 0.5014 | 27.1027027027 | 1.85 | 2.595 | 1.66 | 254000 | 2.06347168 | CS |
52 | 0.6614 | 39.1360946746 | 1.69 | 3.29 | 1.66 | 274996 | 2.23991022 | CS |
156 | -3.3586 | -58.819614711 | 5.71 | 7.22 | 1.33 | 263370 | 2.33370925 | CS |
260 | -2.9786 | -55.8836772983 | 5.33 | 10.3 | 1.33 | 281964 | 3.90019378 | CS |
Symbole | Prix | Vol. |
---|---|---|
SPYSPDR S&P 500 | US$ 591,15 (0,86%) | 122,49M |
SPXSDirexion Daily S&P 500 Bear 3X Shares New | US$ 6,1628 (-3,25%) | 114,87M |
SOXLDirexion Daily Semiconductor Bull 3X Shares | US$ 27,30 (3,80%) | 108,08M |
TSLZT Rex 2X Inverse Tesla Daily Target ETF | US$ 2,435 (7,27%) | 94,23M |
KULRKULR Technology Group Inc | US$ 2,885 (28,79%) | 75,72M |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales